Evidence map›Paper›PMID 39669143›Full record

ReviewHeliyon2024

Cold plasma technology: A cutting-edge approach for enhancing shrimp preservation.

Fataneh Hashempour-Baltork, Adel Mirza Alizadeh, Mansoureh Taghizadeh, Hedayat Hosseini

Abstract readReview
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fataneh Hashempour-BaltorkHalal Research Center of IRI, Iran Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran.
Adel Mirza AlizadehDepartment of Food Safety and Hygiene, School of Public Health, Zanjan University of Medical Sciences, Zanjan, Iran.
Mansoureh TaghizadehDepartment of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hedayat HosseiniDepartment of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold plasma (CP) is an emerging technology employed to safeguard highly perishable food items, particularly aquatic products such as shrimp. Due to its significant amount of moisture, superior protein composition that contains important amino acids, and unsaturated fatty acid content, shrimp are susceptible to microbial deterioration and overall alterations in their physical and chemical characteristics. Such spoilage not only diminishes the nutritional value of shrimp but also has the potential to generate harmful substances, rendering it unsuitable for consumption. Recent observations have indicated a growing market demand for shrimp that maintains its quality and has a prolonged shelf life. Furthermore, there is a significant emphasis on the production of food items that undergo minimal processing or nonthermal preservation methods. Extensive documentation exists regarding the efficacy of CP technology in eliminating microorganisms from shrimp without inducing resistance or activating enzymes that contribute to shrimp spoilage. Therefore, CP can be mentioned as a slight processing interference to preserve shrimp quality. This chapter primarily explores the principles and methods of CP technology, as well as its impact on melanosis, physicochemical changes, microbial and sensory properties, and the preservation of shrimp quality.

Indexed as

Cold plasmaMelanosisMicrobial spoilageQualitySensoryShrimp

Identifiers

PMID39669143
PMCPMC11636109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.